Iowa State Bank’s Perspective Therapeutics CATX Stock Holding History

Iowa State Bank’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$52.4K	Hold	19,061	–	–	0.01%	116
2026 Q2	$65K	Hold	19,061	–	–	0.01%	118
2026 Q1	$79.5K	Hold	19,061	–	–	0.01%	117
2025 Q4	$52.4K	Hold	19,061	–	–	0.01%	120
2025 Q3	$65.4K	Hold	19,061	–	–	0.01%	120
2025 Q2	$65.6K	Hold	19,061	–	–	0.01%	122
2025 Q1	$40.6K	Hold	19,061	–	–	0.01%	119
2024 Q4	$60.8K	Hold	19,061	–	–	0.01%	106
2024 Q3	$254K	Buy	+19,061	New	+$253K	0.05%	104

Other funds holding CATX

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $208M AUM 15.78% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Iowa State Bank's CATX Position: Q3 2026 in Review

Iowa State Bank held its Perspective Therapeutics (CATX) position steady in Q3 2026 at 19,061 shares worth $52.4K. The position accounts for 0.01% of the portfolio, ranked #116.

Iowa State Bank first reported a position in CATX in Q3 2024 and has held it in 9 quarters since. The position peaked at $254K in Q3 2024. 3 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

Iowa State Bank held 19,061 shares of Perspective Therapeutics worth $52.4K as of Q3 2026.
Iowa State Bank left its Perspective Therapeutics share count unchanged in Q3 2026.
Perspective Therapeutics made up 0.01% of Iowa State Bank's portfolio in Q3 2026, its #116 holding.
Iowa State Bank first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 9 quarters since.
Iowa State Bank's Perspective Therapeutics position peaked at $254K in Q3 2024.
3 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Iowa State Bank's 13F filing for Q3 2026, filed 6 Oct 2026.